| Literature DB >> 30793437 |
X Sun1, J Li1, C Fan1, H Zhang1, Y Si2, X Fang3, Y Guo4, J H Zhang5, T Wu1, S Ding1, X Bi1.
Abstract
BACKGROUND ANDEntities:
Keywords: clinical manifestations; corpus callosum infarction; etiology; neuroimaging; prognosis; thrombolysis
Year: 2019 PMID: 30793437 PMCID: PMC6767551 DOI: 10.1111/ene.13942
Source DB: PubMed Journal: Eur J Neurol ISSN: 1351-5101 Impact factor: 6.089
Figure 1Representative images of pure and complex callosal infarction. (a) Pure genu infarction and (b) pure splenium infarction of the corpus callosum. (c,d) Complex callosal infarction. Part c shows infarction of body coupled with basal ganglia region. Part d shows infarction of splenium coupled with basal ganglia region.
Clinical manifestations of the patients with corpus callosal infarction
| Clinical manifestations | |
|---|---|
| Cognitive impairment | 33 (26.0) |
| Mental disorder | 27 (21.3) |
| Sleep disorder | 13 (10.2) |
| Aphasia | 22 (17.3) |
| Sensory abnormality | 26 (20.5) |
| Central facial paralysis | 49 (38.6) |
| Limbs paralysis | 93 (73.2) |
| Hemianopia | 12 (9.4) |
| Ataxia | 10 (7.9) |
| Alien hand syndrome | 1 (0.8) |
Data are given as n (%).
Comparison of clinical features in the three groups
| Pure callosal infarction ( | Complex callosal infarction ( | Basal ganglia infarction ( |
|
|
| |
|---|---|---|---|---|---|---|
| Time from onset to hospital (h) | 144 (1.75, 270) | 24 (8.5, 42) | 7 (4.25, 12) | 0.024 | 0.705 | 0.030 |
| Thrombolytic therapy | 2 (9.5%) | 2 (9.5%) | 7 (33.3%) | 0.087 | 1.000 | 0.133 |
| Hypertension | 15 (71.4%) | 18 (85.7%) | 16 (76.2%) | 0.645 | 0.452 | 0.726 |
| Diabetes mellitus | 12 (57.1%) | 10 (47.6%) | 2 (9.5%) | 0.004 | 0.537 | 0.001 |
| Hyperlipemia | 7 (36.8%) | 11 (52.4%) | 6 (28.6%) | 0.249 | 0.212 | 0.739 |
| Prior stroke | 6 (28.6%) | 2 (9.5%) | 0 (0) | 0.022 | 0.239 | 0.028 |
| Smoking | 8 (38.1%) | 9 (42.9%) | 9 (42.9%) | 0.938 | 0.753 | 0.753 |
| Cancer | 3 (14.3%) | 0 (0) | 1 (4.8%) | 0.312 | 0.231 | 0.599 |
| Number of risk factors | 3 (2, 4) | 3 (1, 4) | 2 (1, 2) | 0.048 | 0.129 | 0.083 |
| Clinical manifestations | ||||||
| Cognitive impairment | 6 (28.6%) | 5 (23.8%) | 0 (0) | 0.030 | 0.726 | 0.028 |
| Mental disorder | 8 (38.1%) | 2 (9.5%) | 0 (0) | 0.002 | 0.030 | 0.006 |
| Sleep disorder | 3 (14.3%) | 0 (0) | 0 (0) | 0.101 | 0.231 | 0.231 |
| Aphasia | 1 (4.8%) | 2 (9.5%) | 3 (14.3%) | 0.864 | 1.000 | 0.599 |
| Sensory abnormality | 3 (14.3%) | 5 (23.8%) | 11 (52.4%) | 0.021 | 0.694 | 0.009 |
| Central facial paralysis | 7 (33.3%) | 10 (47.6%) | 16 (76.2%) | 0.019 | 0.346 | 0.005 |
| Limb paralysis | 12 (57.1%) | 13 (61.9%) | 21 (100.0%) | 0.003 | 0.753 | 0.003 |
| Discharge conditions | ||||||
| Number of paralytic limbs | 1 (0, 2) | 1 (0, 2) | 2 (2, 2) | 0.000 | 0.664 | 0.001 |
| Muscle strength grade | 5 (4, 5) | 4 (4, 5) | 4 (3, 4) | 0.000 | 0.085 | 0.000 |
| NIHSS score | 1 (1, 2) | 1 (1, 2) | 4 (3, 5) | 0.006 | 0.030 | 0.016 |
P ▵value, pure callosal infarction compared with complex callosal infarction; P*value, pure callosal infarction compared with basal ganglia infarction. NIHSS, National Institutes of Health Stroke Scale. Data are given as n (%), median, upper (Q3) and lower (Q1) quartile or mean and SD.
Results of logistic regression for the risk factors of 1‐year mortality in patients with corpus callosum infarction
| Estimation | SE | OR | 95% CI |
| |
|---|---|---|---|---|---|
| Age | 0.0691 | 0.0284 | 1.072 | [1.014–1.133] | 0.015 |
| Mental disorders | 2.0015 | 0.6501 | 7.400 | [2.070–26.462] | 0.002 |
CI, confidence interval; OR, odds ratio; SE, standard error.